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Over 20 years ago, Schade and Caroline (1)  found that an iron-binding protein in 
egg white  was  bacteriostatic.  Since  then  it  has  become clear that  the  competition 
between host and pathogen for trace nutrients, particularly iron, can be an important 
determinant  to  the  virulence  of an  invading  microorganism.  For example,  during 
acute  infections in  mammals, plasma iron  is shifted  toward  the reticuloendothelial 
system, presumably making it less available to invading pathogens (2).  Furthermore, 
iron-binding  proteins such as transferrin  in the plasma and lactoferrin  in secretions 
have been shown to be bacteriostatic, both in vitro and in vivo (3). Many investigations 
have shown that sequestration of iron may be an important initial step in the host's 
defenses against infectious disease (4). 
On  the  other  hand,  many  microorganisms are  able  to  produce  their  own  iron- 
binding  molecules when  faced with  a  low-iron environment  (5).  These compounds 
have iron-binding constants that are comparable to those of transferrin and lactoferrin 
(6)  and would appear to be the pathogen's answer to the host's iron-binding defense 
mechanisms.  Indeed,  the  ability  to produce  these compounds in  vitro is  associated 
with  increased  virulence of many bacteria in  vivo  (7).  However,  these  compounds 
have not been isolated from an infected host. And, although the inability to produce 
these  compounds  may be  associated  with  reduced  virulence,  pathogens  unable  to 
synthesize such compounds are fully capable of producing disease (8). Thus, organisms 
must be able to obtain iron for growth by another mechanism. 
This report describes the partial purification and characterization of a  low molec- 
ular  weight  iron-binding  compound  isolated  from  mammalian  tissue  capable  of 
supplying iron  to, and stimulating the growth  of, several pathogenic bacteria. This 
host-associated  iron  transfer  factor  (HAITF) 1 may  play  an  important  role  in  the 
competition between host and pathogen for iron. 
Materials and Methods 
Reagents.  Chromatographic resins AG-50W-X8 and Chelex-100  were purchased from Bio- 
Rad Laboratories, Richmond, Calif. Sephadex G-10, G-15, G-25, and G-50 gel filtration beads 
were purchased from Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J. 
Desferrioxamine B was obtained from Ciba Pharmaceutical Co.,  Div. of Ciba-Geigy Corp.~ 
Summit, N. J. 
Bacteria.  Salmonella typhimurium mutants TA 2701 and TA 2700 were obtained  from Dr. 
i Abbreviation used in this paper." HAITF, host-associated iron transfer factor. 
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Hugh Akers and  Dr. M.  Luckey (9).  Wild-type pathogenic S. typhimurium, Escherichia coli, and 
Klebsiella pneumoniae were obtained  from isolates from patients with clinical infectious disease. 
Assay for HAITF.  Minimal medium E  of Vogel and Bonner (10)  in  1.5% agar was used as 
low-iron medium. After the medium was prepared,  autoclaved, and cooled to 45°C, a  saline- 
washed suspension ofS. typhimurium TA 2700 was added, and the resultant mixture was poured 
into  100  ×  15-mm Petri dishes. S. typhimurium TA 2700 is an enb mutant  unable to synthesize 
the iron chelator produced by wild-type salmonellae enterobactin, and thus is unable to grow 
on low-iron medium unless supplied with an exogenous iron chelator. 
HAITF activity was assayed by drying 5,  10, or 20 ftl of sample on a 6-mm filter paper disk. 
The disks were placed on the prepared plates and incubated at 37°C for 24 h. The amount of 
activity was determined by recording the mean of three measurements of the distance between 
the edge of the disk and the edge of the halo of growth. 
Amounts of HAITF in  Various Tissues.  Five male  Sprague-Dawley  rats  were  sacrificed  by 
decapitation. The blood was collected and clotted. Each animal was then dissected and samples 
of various organs  were obtained.  The tissue was washed  free of loose blood, patted  dry,  and 
then weighed. The tissue was then homogenized with 9 vol of anhydrous methanol in a Virtis 
homogenizer  (VirTis Co.,  Inc., Gardiner,  N.  Y.).  After the homogenate  was centrifuged,  the 
supernate was decanted and dried overnight in a  dessicator. The dried extract was redissolved 
in  1 vol of 0.025 M  ammonium acetate. Duplicate aliquots (20/tl) of this solution were assayed 
for bioactivity. Blood was analyzed by adding  1.0 ml of serum dropwise to 9.0 ml of methanol. 
After centrifugation,  the supernate  was dried and redissolved in  1.0 ml, 0.025  M  ammonium 
acetate. Aliquots were assayed in duplicate as above. 
Purification of HAITF.  Horse liver was obtained  from a  local abbatoir and  washed  free of 
blood with cold-distilled water. Unless stated otherwise, all steps were performed at 4°C. The 
liver was homogenized at  high speed  in a  Waring blender (Waring Products  Div., Dynamics 
Corp.  of America,  New Hartford,  Conn.)  for 20  min with  an  equal  volume of glass-distilled 
water. The homogenate was centrifuged at 3,000 rpm for 30 min in a  Sorvall RC-5 centrifuge 
(Ivan Sorvall, Inc.,  Norwalk,  Conn.).  The supernate  was subjected  to ultrafiltration  through 
dialysis tubing and  the filtrate recovered. The filtrate was dried by flash evaporation and the 
residue  extracted  with  anhydrous  methanol.  Methanol-insoluble  material  was  removed  by 
filtration. The methanol-soluble extract was lyophilized and stored at  -20°C  for up to 8  mo 
without loss of activity. 
2 g of methanol-soluble extract dissolved in  10 ml of 0.1  M  NaCI was loaded onto a 2.6 ×  32- 
cm column that contained AG 50W-X8 resin (hydrogen form) that had been equilibrated with 
at least  1 liter of distilled I-t20. The column was eluted at room temperature with a 0.1-0.5 M 
NaC1 gradient  and  then with  1.0 M  NaCI.  Fractions that  contained  HAITF bioactivity were 
pooled, dried by rotary evaporation, and the residue extracted several times with methanol. To 
remove iron from the sample, the methanol-soluble material from the AG-50 column was dried 
by rotary evaporation, dissolved in 10 ml of glass-distilled water, and eluted over a column (1.0 
×  18 cm) of Chelex-100 resin that  had been previously washed with  1 M  sodium acetate and 
equilibrated with glass-distilled water. The iron concentration ofeluted fractions was measured 
with a  Perkin-Elmer atomic absorption  spectrophotometer  (model 305B, Perkin-Elmer Corp., 
Instrument Div., Norwalk, Conn.). The iron-free sample of HAITF was then dissolved in 10 ml 
of 0.025  M  ammonium acetate and applied and eluted from a  Sephadex G-50 column (3.0 x 
100 cm) previously equilibrated with 0.025  M  ammonium acetate. 
Assessment of Iron Binding  by HA1TF.  Samples  of HAITF  were  incubated  with  1 /tCi  of 
59FeCl3  (dissolved  in 0.1  /tm  HCI,  13.77  #CI/mg sp act)  and  applied as  1- to  2-mm spots  to 
Whatman  3M chromatography  paper  (Whatman,  Inc., Clifton, N. J.). Samples of HAITF or 
59FEC13 alone were also spotted  as controls.  Ascending chromatography  was  performed  with 
propanohwater  (70:30  vol/vol). The various lanes of the chromatograms  were either sprayed 
with  1% FeC13 solution  to test  for iron staining,  cut  into segments and counted  in a  Packard 
gamma counter  (model  575,  Packard  Instrument  Co., Inc.,  Downers Grove, I11.), or disks  (6 
ram)  were punched out and assayed for hioactivity. 
Samples of HAITF incubated with ~gFeCI3 were also applied to Sephadex G-10, G-15, G-25, 
or G-50 columns.  The columns were eluted at  4°C with 0.025  M  ammonium  acetate buffer, 
and the resulting fractions were counted for S9Fe radioactivity and assayed for bioactivity. 
Iron-Uptake Experiments.  Iron-uptake  experiments were performed by the method of Peters 420  LOW  MOLECULAR WEIGHT IRON-BINDING FACTOR 
and Warren  (11).  These experiments were carried out with resting cells grown to a  density of 
109 bacteria/ml in low-iron medium.  15-ml suspensions were placed in 25-ml Erlenmeyer flasks. 
59FEC13 in  saline  solution  was  added  to  each  flask  either  with  or  without  added  HAITF. 
Suspensions  were  agitated  in  a  shaking  water  bath  at  37°(2.  Aliquots  were  withdrawn  at 
intervals and filtered through 0.45-#m Millipore filters (Millipore Corp., Bedford, Mass.). The 
filters  were  flushed  with  low-iron  medium  and  counted  in  a  gamma  counter  for  retained 
radioactivity. 
Bacterial Growth-Curve Experiments.  Organisms were grown overnight in nutrient  broth  and 
washed  three  times  with  sterile  saline.  Aliquots  (20  #1)  of a  suspension  that  contained  109 
organisms/ml were added to 1 ml of sterilized (0.45 #m Millipore filter) liquid minimal medium 
to  which  had  been  added  a  solution  of  HAITF  or  sterile  saline.  Growth  was  followed 
spectrophotometrically at 450 nm in a Coleman spectrophotometer (Coleman Systems, Irvine, 
Calif.). 
Effect  on  HAITF  on  Bacterial  Infection  In  Vivo.  Male  8-  to  10-wk-old  BALB/c  mice  were 
infected with wild-type S. typhimurium (Fig. 7 A) or mutant S. typhimurium TA 2701  (Fig. 7 B) by 
an  intraperitoneal  injection.  At  the  time  of  infection,  they  began  receiving  subcutaneous 
injections of a sterilized solution of HAITF. Injections of 0.1  ml HAITF (850 U/ml) were given 
every 6  h  and  continued  until  six  injections were  received by each  mouse.  The  number  of 
survivors in each group of mice was recorded every 6 h. Results were analyzed statistically by 
the Stromgen method of life-table analysis (12). 
Results 
Assay for HAITF.  HAITF bioactivity was quantitated by measuring the distance 
between the edge of a filter paper disk saturated with sample and the outer edge of a 
halo of bacteria growing around the disk.  Fig.  1 shows the response (in millimeters of 
growth) after 24 h of incubation with varying amounts of HAITF. A unit is defined 
as  1 mm of growth of TA 2700 in 24 h at 37°C. 
Amount of HAITF in  Various Tissues.  The methanol-extractable bioactivity of var- 
ious tissues  of the rat is seen in Table I. The results are expressed as units per gram 
tissue.  The  liver  is  the  tissue  with  the  highest  amounts  of methanol-extractable 
bioactivity  and  the  brain  is  the  lowest.  All  tissues  and  blood  serum  exhibited 
bioactivity. 
Purification.  The  purification  scheme  together  with  the  degree  of purification 
achieved is shown in Fig. 2. Horse liver homogenized with distilled water had a 0.51 
U/mg sp act. Centrifugation, ultrafiltration,  and methanol extraction increased the 
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FIG.  l.  Relationship of amount  of HAITF sample  placed on  filter paper  disk  for  bioassay  to 
hioactivity. Amount is represented by microliters  of sample and bioactivity by units (one unit =  1 
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Rat  Blood  Brain  Spleen  Liver  Heart  Kidney  Bowel  Lung 
U/g tissue 
1  800  800  875  990  850  910  1,015  700 
2  650  765  840  1,015  950  940  715  790 
3  650  790  1,090  975  765  965  800  790 
4  675  765  865  1,115  740  875  850  815 
5  625  765  925  1,090  825  965  790  825 
Mean±  680±69.4  7774-16.8  919±100.5  1,037±62.1  8264"82.3  931±38.6  834 ±  II2A  784±49.4 
I SD 
Horse Liver Homogenate CSA  = 0.51 units/mq) 
dialysis,  methanol  extraction 
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FIG.  2.  Purification scheme of HAITF.  SA =  specific activity in units per milligram of dry sample. 
specific activity to 5.37 U/mg. Cation-exchange chromatography on AG 50-X8 resin 
resulted in the HAITF activity being eluted with  1 M  salt. This solution contained a 
large amount of iron as measured  by atomic absorption spectrometry (0.189  mg of 
iron/mg of sample). To dissociate HAITF activity from that of inorganic  iron, the 
sample was passed through an iron-binding resin, Chelex-100,  (sodium form) at pH 
5.6.  The specific HAITF activity of the sample after iron  removal was  14  U/mg, 
whereas the iron content was reduced to 0.003/~g/mg. 
The  sample was  evaporated  to  dryness  and  redissolved  in  0.025  M  ammonium 
acetate buffer and placed on a column of Sephadex G-50. The specific activity of the 
peak of activity eluted from this column was 28 U/mg. The overall purification from 
horse liver homogenate was -54-fold. 
Iron-Binding Assays.  Samples of HAITF incubated  in  the presence or absence of 
59FeC18 were applied to paper chromatograms as was 59FEC13 alone. After ascending 
chromatography, a lane that contained HAITF incubated with 59FEC13 and a lane of 
~9FeC13 alone were cut  into  5-mm segments and counted  for radioactivity.  HAITF 
bioactivity was  assayed by cutting  6-mm disks  from lanes  that  contained  HAITF, 
HAITF with S9FeCl3, and 59Fe(]13 alone. A  peak of radioactivity was found to move 
from the origin with an Rf of 0.61 in the lane with HAITF incubated with 59FeCIa. No 
migration of radioactivity was seen in the lane with 59FEC13 alone. HAITF bioactivity 
was not seen in the lane with  59FEC13 alone but was seen as a  broad peak in  those 
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F[c.  3.  Elution profiles of HAITF and 5~FeCI3 on gel filtration columns. V0 = exclusion volume. 
Units HAITF represents millimeters of growth in 24 h. (C)) Bioactivity 24 h (millimeters of growth); 
(O) radioactivity (cpm). 
tained  HAITF and HAITF plus 59FEC13 were sprayed with  1% FeC13.  Both of these 
lanes showed pink staining areas with an Rf of 0.55. 
Samples of HAITF that had been incubated with 59FEC13 were eluted over Sephadex 
G-10, G-15, G-25, and G-50 columns.  Both bioactivity and radioactivity were found 
in  the  exclusion  volume  of G-10  and  G-15  columns  (Fig.  3).  Radioactivity  and 
bioactivity were  retained  and  coeluted  from G-25  (volume  of elution/void  volume 
[Ve/Vo] =  1.23)  and G-50 (Ve/Vo =  1.9) columns. 
Iron Uptake by Bacteria.  The effect of HAITF activity on iron uptake by wild-type 
S. typhimurium in a  low-iron medium was determined by comparing uptake of 59FEC13 
with and without  added  HAITF (Fig. 4  A). Iron uptake  by wild-type salmonella  in 
the presence of HAITF is increased by ~25%. To examine the specificity of the iron- 
uptake  phenomena,  the same experiments  were repeated  with  the mutant  TA 2701 
(Fig.  4  B).  This  experiment  was  carried  out  with  TA 2701  and  desferrioxamine  as 
above.  Again,  HAITF  stimulated  iron  uptake,  whereas  the  presence  of 5  /~M  of 
desferrioxamine  significantly  inhibited  the  iron  uptake  in  the  presence  of HAITF. 
The  presence  of desferrioxamine  alone  completely  inhibits  iron  uptake  by  these 
bacteria. 
Bacterial Growth Stimulation.  In  addition  to  its  effect  on  the  salmonella  mutant, 
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FIG.  4.  (A) Iron uptake in wild-type S. typhimurium. Each point represents  counts retained on 0.45- 
~m filters from aliquots of bacterial suspensions.  Tile suspensions contained SOFeCl3 +  200/LI saline 
or 200 ~1 of HAITF. (B) Iron uptake in S. typhimurium  TA 2701. Bacterial  suspensions were incubated 
with SgFeCl3 and  200 #1 HAITF (Q), 200 #1 saline  (F-I), 200/LI HAITF +  5 jaM desferrioxamine 
(A), or 5 ~M desferrioxamine  (C)). Aliquots were filtered over 0.45-/1m filters and retained radioac- 
tivity determined. 
5  A  shows the growth  of S.  typhimurium  with  varying amounts  of HAITF.  Significant 
dose-dependent,  lag-phase  reduction  of  the  growth  curves  suggests  promotion  of 
growth  by  an  iron-chelating  mechanism  because  this  is  a  pattern  typical  for  iron- 
chelating  compounds  (12).  Fig.  5  B  shows  the  results  of similar experiments  carried 424  LOW  MOLECULAR  WEIGHT IRON-BINDING FACTOR 
A  Salmonella  Typhimurium (wild  type) 
o2o- 
o 
2  4  6  8  10  12  14  16  18  20  22  24 
hours 
s  E Coli 
0.20  x--~ 
01~  ///S 
010  ~  /  C) 
O o.o+ 
,  ,  ,  , 
2  4  6  8  I0  12  14  16  18  20 
Klebsiella  Pneumoniae 
2  4  6  8  t0 12 14  16  18  20 
hours 
Fie.  5.  (A)  Growth  of wild-type S.  typhimurium  measured  by  optical  density  (OD)  for  various 
additions of HAITF. Growth recorded every  1-2 h and  1.0/d  (O),  10/d  (A), or 20 #1  (X)  HAITF 
was added.  (B) Growth of E. coli and K. pneumoniae measured by optical density (OD). Growth was 
recorded every 1-2 h and 0.1/~1 (O),  10/~1 (Z&), or 20/d (X) HAITF was added.  (O) no addition. 
out with E. coli and K. pneumoniae.  Again, lag-phase reductions are demonstrated and 
are proportional to the amount of HAITF added to the culture medium. 
To  further  test  the  hypothesis  that  growth  stimulation  of bacteria  by HAITF is 
related  to iron chelation,  an experiment  with a  competing iron-chelating compound 
was performed. Fig. 6 shows the growth curves of TA 2701 in low-iron medium in the 
presence of HAITF together with varying concentrations of desferrioxamine.  Increas- 
ing  the  concentration  of desferrioxamine  prevents  the  reduction  of the  lag  phase 
produced  by HAITF.  Presumably,  desferrioxamine  is competing for the iron in  the 
media, making it unavailable to both HAITF and the mutant salmonella. 
Effect of HAITF on Bacterial Infections  In  Vivo.  The effect of HAITF on Salmonella 
infection in mice is seen in Fig. 7 A and B. HAITF potentiates wild-type S. typhimurium 
infection as seen in Fig.  7 A. No deaths were seen  in the noninfected control groups 
that  received injections of HAITF or saline.  The survival of the infected  group that 
received  HAITF was significantly less than  the infected group that  received normal 
saline. 
To illustrate  competition of this  potentiation  by another iron-binding compound, 
the mutant  salmonella TA 2701  was used as above as the infectious agent.  Fig.  7 B JONES,  PETERSON,  GRADY,  AND  CERAMI 
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FIc.  6.  Growth curves of S.  typhimurium TA 2701  in low-iron medium in the presence of HAITF 
together with varying concentrations of desferrioxamine. (X)  20 #1 HAITF;  (A)  20 #1 HAITF +  1 
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FIG.  7.  (A)  Probability of survival  vs.  time of mice infected with wild-type S.  typhimurium  and 
treated with injections of HAITF (O) or saline (0). HAITF injections significantly reduce survival 
when compared with mice that received saline injections; P  <  0.001  at  1.9 d.  (B)  Probability of 
survival vs. time of mice infected with mutant S. typhimurium TA 2701  and treated with injections of 
HAITF alone (O), HAITF +  desferrioxamine (DES) (X), DES alone (A), or saline (0). Desferriox- 
amine produces a  protective effect in mice also given HAITF when compared with HAITF alone; 
0.05 <  P <  0.10 at 4.25 d. Desferrioxamine treatment alone also produces a  protective effect when 
compared with HAITF alone (P <  0.01  at 4.25 d), or with saline injections (P <  0.01  at 6.46 d). 426  LOW  MOLECULAR  WEIGHT  IRON-BINDING FACTOR 
shows the results of four groups of mice infected with TA 2701.  Each group received 
HAITF alone (group I), HAITF plus desferrioxamine (25 mg/kg)  (group II), desfer- 
rioxamine  alone  (25  mg/kg)  (group  III),  or  normal  saline  (group  IV).  Group  I 
exhibited  reduced  survival compared with  group  IV as  in  the  wild-type infection. 
Furthermore,  groups  II  and  III,  which  received  HAITF  and  desferrioxamine  or 
desferrioxamine  alone,  were  protected.  This  suggests  a  competitive effect  between 
HAITF and desferrioxamine in vivo. 
Discussion 
These experiments indicate  the presence of a  low molecular weight  iron-binding 
compound in mammalian tissue that  is capable of stimulating the growth of enteric 
bacteria in  low-iron  medium.  The fact that  the compound  is dialyzable places the 
molecular weight of the compound at < 10,000.  Furthermore, results of exclusion from 
gel filtration columns suggest that  the factor has a  molecular weight between  1,500 
and 5,000.  As isolated, the material is associated with iron that can he removed with 
Chelex-100 resin without loss of bioactivity. 
Experiments employing radiolabeled iron indicate that HAITF will bind iron and 
that this iron migrates with the bioactivity in both a paper chromatographic system 
and  on  gel  filtration  columns.  It  is  interesting  that  in  the  paper chromatographic 
system the  iron-staining  spot  migrates somewhat  behind  the  radioactivity whereas 
both peaks are associated with bioactivity. This suggests that the iron-bound form of 
the molecule is less polar than the apo-form of HAITF. 
Our  results  also show  a  lag-phase reduction  of the  growth  curve of wild-type S. 
typhimurium,  E.  coli, and K. pneumoniae when grown  in  the presence of HAITF. This 
pattern  has  frequently  been  reported  with  iron-binding  compounds  of microbial 
origin, both catecholates and hydroxamates (13).  We have also shown an inhibition 
of growth stimulation  by desferrioxamine in an organism unable to utilize  the iron 
chelate of desferrioxamine. Additional evidence that iron chelation plays a role in the 
interaction of HAITF and bacteria is supplied by the iron-uptake experiments. Iron 
uptake by resting wild-type S. typhimurium was increased by the addition of HAITF to 
the  medium.  Because  the  organisms  were  grown  in  low-iron  medium,  they  were 
undoubtedly  producing  enterobactin  so  that  addition  of HAITF  stimulates  iron 
uptake over and  above the  inherent  potential  of the  bacteria.  Stimulation  of iron 
uptake by HAITF was also inhibited  by desferrioxamine in  the mutant  salmonella 
unable  to  utilize  desferrioxamine  as  an  iron  donor.  Again  these  results  indicate 
HAITF can act as an iron donor to bacteria. 
In vitro promotion of bacterial growth by HAITF is mirrored in vivo by the results 
shown in Fig. 7 A and B. Theoretically, the amounts of HAITF injected were enough 
to raise the extracellular hioactivity of the host to twice the normal level. The results 
show that HAITF injections significantly reduce the survival of infected animals. As 
in the in vitro experiment, the mutant model suggests that increased bacterial growth 
manifested  by reduced  host  survival  is  secondary  to  increased  iron  uptake  by the 
pathogen. It is possible that injections of semipurified HAITF exert a  toxic effect on 
the animals that lowers their resistance to the pathogen and that the protective effect 
of desferrioxamine is not associated with competition for iron with HAITF. However, 
the animals that received HAITF alone that were not infected showed no deaths or 
signs of toxicity. JONES,  PETERSON,  GRADY, AND CERAMI  427 
HAITF  bioactivity  was  found  in  all  tissues  examined  that  included  serum.  It 
appears to be an ubiquitous substance, but the highest  levels were found in the liver 
and spleen.  This may be significant  in light of the higher level of iron stores in these 
tissues. 
Very  little  is  known  about  small  molecular  weight  iron-binding  molecules  in 
mammalian  tissues  or their  interaction  with  bacteria.  It  is  known that  compounds 
used to treat iron overload such as desferrioxamine or 2,3-dihydroxybenzoic acid can 
promote the virulence of microorgansims by the iron-chelating properties of the durg 
(8).  We have described a low molecular weight factor in mammalian tissue with iron- 
binding properties  that  is capable of promoting bacterial  growth. The physiological 
function of HAITF activity may be involved in cellular iron transport, a phenomenon 
that is not well characterized.  However, whatever its function, HAITF may inadver- 
tently  supply  iron  to  invading  pathogens.  Further  work  is  needed  to  define  its 
structure,  its  role  in  normal  iron  metabolism,  and  its  relationship  to the  process of 
infection. 
Summary 
A  low  molecular weight,  iron-binding  factor was  isolated  from horse  liver.  This 
host-associated iron transfer factor (HAITF) is capable of binding iron and stimulating 
bacterial  growth  by promoting  iron  uptake  into  bacteria.  Also, when  injected  into 
infected  animals,  HAITF  increases  the  virulence  of bacterial  infections.  HAITF 
bioactivity is ubiquitous  in animal  tissues  and present  in serum.  It is proposed  that 
HAITF is a  factor that inadvertently plays a  role in the host-parasite competition for 
iron. 
Received  for publication 23January 1979 and m revised  form  7 November 1979. 
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